期刊文献+

JNK通路对亚急性帕金森病MPTP模型小鼠黑质COX-2表达的影响 被引量:3

Influence of JNK signaling pathway on COX-2 expression in substantia nigra of the mouse models of subacute Parkinson's disease induced by MPTP
下载PDF
导出
摘要 目的:研究JNK在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)所致小鼠帕金森病(PD)模型中对环氧合酶-2(COX-2)的表达调控作用,以探讨可能导致PD黑质多巴胺(DA)能神经元变性失活的机制.方法:采用MPTP制备亚急性PD小鼠模型,观察模型小鼠行为学变化,观察PD模型小鼠黑质区酪氨酸羟化酶(TH),COX-2,磷酸化c-Jun的表达变化;观察给予JNK通路特异性抑制剂SP600125对上述变化的影响.结果:与对照组小鼠相比,模型组小鼠出现典型PD症状,在MPTP第3次注射后6h,黑质区COX-2阳性细胞显著增加,p-c-Jun特异性表达于黑质区细胞核内,在MPTP第5次注射后7d,黑质区TH阳性神经元显著丢失65%(P<0.01);经SP600125处理后,模型小鼠PD症状减轻,与对照组比较,在MPTP第5次注射后7d,TH阳性细胞数仅下降约15%,与模型组比较,在MPTP第3次注射后6h,黑质区COX-2阳性细胞明显减少(P<0.01),黑质区p-c-Jun表达于细胞质内.结论:JNK通路在亚急性PDMPTP模型早期对黑质COX-2表达中可能起重要调控作用;抑制JNK通路对PD小鼠具有神经保护作用. AIM: To investigate the effect of c-Jun N-terminal protein kinase (JNK) on the expression of cyclooxygenase-2 (COX-2) in substantia nigra (SN) of the mouse models of subacute Parkinson's disease (PD) induced by 1-Methyl-4- phenyl- 1,2,3,6-tetrahydropyfidine (MPTP) and to further explore the possible mechanism of the dopaminergic (DA) neuron death in PD. METHODS: C57BL/6N mice were administrated with MPTP to produce subacute PD model. PD mice were observed in behavioral changes. Inmmunohistochemistry for tyrosine hydroxylase(TH) , COX-2 and phosphorylated c-Jun (p-c-Jun) was used to observe the changes in positive cell number in the midbrain and further observe the number changes after treated with SP600125, a specific JNK inhibitor. RESULTS: Compared with the mice in control group, the model mice had the typical symptoms of PD. The number of COX-2 immunoreactive ceils was significantly increased and p-c-Jun was specially expressed in the nucleus of nigral neurons in SN area at 6 h after the 3rd injection of 30 mg/ kg MPTP. The number of TH-positive neurons in model group was distinctly reduced by about 65% (P 〈0.01 ) in the SN 7 d after the 5th injection of MPTP. In JNK inhibitor SP600125 group, the number of TH-positive neurons in SN was only decreased by 15% (P 〈0.01 vs control group) 7 d after the 5th injection of MPTP, the number of COX-2 positive cells was clearly reduced as compared with the model group ( P 〈 0.01 ), p-c-Jun was expressed mainly in the cytoplasm of nigral neurons at 6 h after the 3rd injection of MPTP. CONCLUSION: JNK signaling pathway may play an important role in mediating COX-2 expression in SN in the early stage of the MPTP-induced subacute PD, so inhibiting JNK activity may have neuroprotection to the PD mouse models.
出处 《第四军医大学学报》 北大核心 2007年第11期979-982,共4页 Journal of the Fourth Military Medical University
基金 河北省自然科学基金(C2004000689) 河北省博士基金(05547008D-4) 河北省科学技术与社会发展计划(04276135)
关键词 帕金森病 炎症 环氧合酶-2 C-JUN氨基末端激酶 磷酸化c-Jun Parkinson's disease inflammation COX-2 JNK p-c-Jun
  • 相关文献

参考文献8

  • 1Hald A,Lotharius J.Oxidative stress and inflammation in Parkin-son's disease:Is there a causal link[J]? Exp Neurol,2005,193(2):279-290.
  • 2师亮,张宇新,张作凤,陈浩.COX-2对帕金森病小鼠黑质内多巴胺能神经元的毒性作用[J].第四军医大学学报,2006,27(18):1661-1664. 被引量:9
  • 3Nieminen R,Leinonen S,Lahti A,et al.Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes[J].Mediators Inflamm,2005,2005(5):249-255.
  • 4Smeyne RJ,Jackson-Lewis V.The MPTP model of Parkinson's disease[J].Brain Res Mol Brain Res,2005,134(1):57-66.
  • 5Wang T,Pei Z,Zhang W,et al.MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration[J].FASEB J,2005,19(9):1134-1136.
  • 6Chen H,Zhang SM,Hernan MA,et al.Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease[J].Arch Neurol,2003,60(8):1059-1064.
  • 7Xia XG,Harding T,Weller M,et al.Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of parkinson's disease[J].Proc Natl Acad Sci U S A,2001,98(18):10433-10438.
  • 8Hunot S,Vila M,Teismann P,et al.JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease[J].Proc Natl Acad Sci U S A,2004,101(2):665-670.

二级参考文献14

  • 1Teismann P, Vila M, Choi DK, et al. COX-2 and neurodegeneration in Parkinson's disease [J]. Ann N Y Acad Sci, 2003, 991: 272 - 277.
  • 2Smith WL, Garavito RM, DeWitt DL. Prosteglandin endoperoxide H synthase ( cyclooxygenases)-1 and 2 [J]. J Biol Chem, 1996,271 (52) :33157 -33160.
  • 3Petroske E, Meredith GE, Callen S, et al. Mouse model of parkinsonism: A comparison between subacute MPTP and chronic MPTP/PROBENECID treatment [J]. Neuroscience, 2001, 106 ( 3 ) :589 - 601.
  • 4Grubbs C J, Lubet RA, Koki AT, et al. Celecoxib inhibits N-Butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female fischer-3d4 Rats[J]. Cancer Res,2000,60( 20 ) :5599 - 5602.
  • 5萨姬布鲁克.分子克隆实验指南[M].2版,北京:科学出版社,1999:873—897.
  • 6Wang W, Shi L, Xie Y, et al. SP600125, a new JNK inhibitor,protects dopaminergic neurons in the MPTP model of Parkinson's disease[J]. Neurosci Res, 2004,48(2):195-202.
  • 7Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases [J]. J Neuropathol Exp Neurol, 2004,63(9) :901 -910.
  • 8Teismann P, Tieu K, Cohen O, et al. Pathogenic role of glial cells in Parkinson's disease[J]. Mov Disord, 2003,18(2) :121 - 129.
  • 9Teismann P, Ferger B. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease[J]. Synapse , 2001,39(2) :167 - 174.
  • 10Feng ZH, Wang TG, Li DD, et al. Cyclooxygenase-2-deficient mice are resistant to 1-methyl4-phenyll, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra[J].Neurosci Lett, 2002,329( 3 ) :354 - 358.

共引文献8

同被引文献35

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部